Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry
The Brazilian pharmaceutical industry is heavily dependent on external sources of inputs, capital, and technology. However, the emergence of technological opportunities and the development of biotechnology and the decline of the patent boom and resulting advances by generic drugs have opened windows...
Saved in:
Published in | Cadernos de saúde pública Vol. 32Suppl 2; no. Suppl 2; p. e00103315 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English Portuguese |
Published |
Brazil
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz
01.01.2016
Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The Brazilian pharmaceutical industry is heavily dependent on external sources of inputs, capital, and technology. However, the emergence of technological opportunities and the development of biotechnology and the decline of the patent boom and resulting advances by generic drugs have opened windows of opportunities for the local industry. The article examines the Brazilian industry's innovative behavior vis-à-vis these opportunities, showing that although the industry as a whole invests little in innovation, a few large Brazilian companies have expanded their market share and stepped up their investments in research and development, supported by public policies for innovation. Resumo: A indústria farmacêutica brasileira caracteriza-se pela grande dependência de fontes externas de insumos, capital e tecnologia. O surgimento de oportunidades tecnológicas, associadas ao desenvolvimento da biotecnologia e ao fim do boom das patentes com o consequente avanço dos medicamentos genéricos, entretanto, vem abrindo janelas de oportunidades para a indústria local. Este artigo examina o comportamento inovador da indústria brasileira à luz dessas oportunidades, revelando que, embora o conjunto da indústria mantenha baixos níveis de investimentos em inovação, um pequeno grupo de grandes empresas nacionais vem ampliando sua participação no mercado e intensificando seus investimentos em pesquisa e desenvolvimento, apoiados por políticas públicas de inovação. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0102-311X 1678-4464 1678-4464 0102-311X |
DOI: | 10.1590/0102-311X00103315 |